Status:
COMPLETED
Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer
Lead Sponsor:
UCSF Benioff Children's Hospital Oakland
Conditions:
Basal Cell Carcinomas
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
Brief Summary
Human Basal Cell Carcinomas (BCCs) can be ablated by treating them with nanosecond pulsed electric fields (nsPEF)
Detailed Description
The purpose of this study is to determine if low energy, non-thermal, 100 ns pulses can ablate BCCs. The investigators consider this a non-significant risk study because our PulseCure system only appl...
Eligibility Criteria
Inclusion
- Study subjects must have had diagnosed at least one BCCon their trunk
- The subject is from 18-75 years of age, inclusive.
- The subject must sign and date all informed consent statements.
Exclusion
- The subject is exhibiting signs of a bacterial or viral infection, including fever.
- The subject is unwilling to allow a biopsy of a malignant lesion for histological analysis.
- The subject has a pace maker or other electronic device implanted
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01463709
Start Date
October 1 2011
End Date
June 1 2012
Last Update
February 21 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Research Center Oakland
Oakland, California, United States, 94609